Authorized Representative

U.S. FDA Agent for Medical Devices

A foreign medical device establishment that manufactures, prepares, propagates, compounds or processes a device imported into the United States must designate a U.S. Agent with the FDA. The FDA-defined role is limited: the agent acts as a communication link between the FDA and the foreign establishment. It is not, by itself, product registration, FDA clearance or approval.

USA Authorized Representative: Key Information

Requirement

Details

Regulatory authority

U.S. Food and Drug Administration (FDA)

FDA term

U.S. Agent

Who needs one

A foreign establishment within the FDA’s U.S. Agent requirement must identify an agent as part of its establishment registration information.

Number of agents

Each foreign establishment may designate only one U.S. Agent.

U.S. Agent location

The agent must reside in the U.S. or maintain a place of business there. A P.O. box or answering service alone is not acceptable.

How it is designated

The foreign establishment submits the agent’s details electronically through FDA’s FURLS system as part of establishment registration. The agent must confirm consent through FDA’s email verification process.

FDA fee for the U.S. Agent designation

The FDA’s published fee schedule lists establishment registration fees and product submission fees, but no separate FDA fee for the U.S. Agent designation itself.

Annual establishment registration fee

US$13,785 for FY 2027 (October 1, 2026–September 30, 2027), for establishments required to register and pay. This is an establishment fee, not an agent-service fee.

Product authorization

FDA registration and listing do not mean that a device is cleared, approved or authorized for sale. The required premarket pathway depends on the device.

The FDA requires an agent to confirm that they agree to act in this role. If the agent declines or does not respond within 10 business days, the foreign establishment must designate another agent.

What Is a U.S. Agent?

A U.S. Agent is the U.S.-based contact designated by a qualifying foreign medical device establishment in its FDA registration information. The agent helps FDA communicate with the foreign establishment and responds to FDA questions about the establishment’s devices imported or offered for import into the U.S.

 The FDA describes the agent’s responsibilities as limited. Designating a U.S. Agent does not automatically make that company the device’s importer, distributor or U.S. regulatory authorization holder. The manufacturer and agent should agree in writing on the scope of any additional services.

Is a U.S. Agent the Same as an EU Authorized Representative?

No. “U.S. Agent” is the FDA’s term for this role. It is not the same legal role as an EU Authorized Representative under the EU Medical Device Regulation.

The FDA describes the U.S. Agent’s duties as communications and assistance with inspection scheduling. The U.S. Agent is not responsible for submitting 510(k) Premarket Notifications or reporting adverse events under the Medical Device Reporting regulation.

Is a U.S. Agent Required?

A foreign establishment covered by the FDA requirement must identify a U.S. Agent as part of its initial and updated registration information. The agent must either reside in the United States or maintain a U.S. place of business. It must be reachable by telephone during normal business hours; a P.O. box or answering service alone does not meet the FDA’s stated requirements.

What Does the U.S. Agent Do?

The FDA lists these responsibilities for a U.S. Agent:

  • Assist with FDA communications: Help FDA communicate with the foreign establishment.
  • Respond to FDA questions: Respond to questions concerning the establishment’s devices imported or offered for import into the United States.
  • Assist with inspection scheduling: Help FDA arrange inspections of the foreign establishment.
  • Receive communications when needed: If FDA cannot contact the foreign establishment directly or promptly, it may provide documents or information to the U.S. Agent. FDA considers that equivalent to providing them to the foreign establishment.
  • Confirm the appointment: Respond to FDA’s electronic verification request to confirm consent to act as the agent.
  • The role does not automatically include product submissions, importer responsibilities, complaint handling or adverse-event reporting. The foreign manufacturer remains responsible for meeting applicable FDA requirements.

    U.S. Agent, Establishment Registration, Device Listing and FDA Authorization Are Different

These terms describe different regulatory activities:

U.S. Agent designation

Identifies the U.S.-based contact for the qualifying foreign establishment.

Establishment registration

Provides FDA with information about the establishment. Device establishments required to register generally renew their registration annually.v

Device listing

Identifies devices and activities associated with establishments required to list.

Premarket submission or authorization

Depending on device type and applicable exemptions, a device may require a 510(k), De Novo request, Premarket Approval (PMA) or another regulatory pathway before it can be marketed.

 FDA states that establishment registration and device listing do not denote FDA approval, clearance or authorization. FDA also does not issue registration certificates to medical device facilities.

U.S. Agent Appointment and FDA Registration Process

1. Confirm which establishment needs an agent

Review the foreign manufacturer’s activities and the device’s route to the U.S. market. The FDA’s requirements depend on establishment activity and device status.

2. Select an eligible U.S. Agent

Confirm that the proposed agent resides in the U.S. or maintains a physical place of business there, can be reached during normal business hours and agrees to take on the role.

3. Define the service scope

Document the agent’s communication and inspection-scheduling responsibilities. Agree separately on any additional support, such as registration coordination or regulatory consulting.

4. Submit the agent details through FDA’s system

The foreign establishment submits the agent’s contact details through FURLS as part of establishment registration. Only one U.S. Agent may be designated for each foreign establishment. The agent must complete FDA’s consent verification.

5. Complete applicable establishment registration and device listing

Determine which establishments must register, which must list devices and which must pay the establishment fee. The requirements vary by establishment activity.

6. Assess the device’s separate premarket requirements

Determine whether the device is exempt from premarket review or requires a 510(k), De Novo request, PMA or another pathway. The U.S. Agent designation does not provide or replace product clearance or approval.

7. Maintain accurate registration information

FDA requires annual verification of registration information for establishments that must register. Review the contact details and agent appointment when information changes.

How OMC Medical Can Support Your U.S. Market Entry

OMC Medical can help manufacturers plan the regulatory work around their U.S. Agent appointment, including:

  • Reviewing whether the foreign establishment is subject to the U.S. Agent requirement.
  • Helping define the roles of the manufacturer, U.S. Agent and U.S. importer.
  • Coordinating U.S. Agent appointment details and FDA consent confirmation through an eligible U.S.-based arrangement, where included in the agreed scope.
  • Supporting FDA establishment registration and device listing coordination.
  • Helping assess whether the device may require a 510(k), De Novo request, PMA or another pathway.
  • Organizing registration and submission information and helping track FDA communications.
  • Clarifying which FDA fee applies to the establishment or product submission, separately from private service fees.

Looking for a U.S. Authorized Representative?

Plan your FDA U.S. Agent appointment alongside establishment registration, device listing and any required product authorization. Contact OMC Medical to discuss your establishment and device pathway.

Book a Free Consultation

 Call: +44 208 066 7260

Email: sales@omcmedical.com

Frequently Asked Questions

A U.S. FDA Agent is a U.S.-based contact designated by a qualifying foreign medical device establishment to communicate with the FDA regarding its establishment and devices

Yes. Foreign establishments subject to FDA’s registration requirements must designate a U.S. Agent as part of their establishment registration information.

The agent helps facilitate FDA communications, responds to FDA questions concerning the establishment’s devices, and assists with scheduling inspections. The role does not automatically include product submissions or adverse event reporting.

No. A U.S. FDA Agent serves as a communication contact for the FDA, while an EU Authorized Representative has a separate legal role under the EU Medical Device Regulation.

No. Appointing an agent does not mean a device is FDA-approved or cleared. Depending on the device, separate premarket authorization, such as 510(k), De Novo, or PMA, may be required.

The foreign establishment selects an eligible U.S.-based agent and submits the agent’s details through the FDA’s registration system. The agent must confirm consent through FDA’s electronic verification process.

Ready to Streamline Your Regulatory Compliance?

Join hundreds of companies who trust OMC Medical for their regulatory needs.

LinkedIn Message on LinkedIn WhatsApp Start WhatsApp chat Call Call us